Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Hari P, Kroft SH.

Br J Haematol. 2011 May;153(3):408-11. doi: 10.1111/j.1365-2141.2010.08555.x. Epub 2011 Jan 31. No abstract available.

PMID:
21275968
2.

CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms.

Dorfman DM, Shahsafaei A.

Am J Clin Pathol. 2010 Nov;134(5):726-33. doi: 10.1309/AJCP38XRRUGSQOVC.

PMID:
20959655
3.

Hematogones: a review and update.

Sevilla DW, Colovai AI, Emmons FN, Bhagat G, Alobeid B.

Leuk Lymphoma. 2010 Jan;51(1):10-9. doi: 10.3109/10428190903370346. Review.

PMID:
20001239
4.

Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

Seegmiller AC, Kroft SH, Karandikar NJ, McKenna RW.

Am J Clin Pathol. 2009 Dec;132(6):940-9. doi: 10.1309/AJCP8G5RMTWUEMUU.

PMID:
19926587
5.

Immunophenotypic variations in mantle cell lymphoma.

Gao J, Peterson L, Nelson B, Goolsby C, Chen YH.

Am J Clin Pathol. 2009 Nov;132(5):699-706. doi: 10.1309/AJCPV8LN5ENMZOVY.

PMID:
19846810
6.

The molecular characterization and clinical management of multiple myeloma in the post-genome era.

Zhou Y, Barlogie B, Shaughnessy JD Jr.

Leukemia. 2009 Nov;23(11):1941-56. doi: 10.1038/leu.2009.160. Epub 2009 Aug 6. Review.

7.

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.

Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, Conticello C, Villari L, Di Raimondo F.

Leuk Res. 2009 Sep;33(9):1212-6. doi: 10.1016/j.leukres.2009.01.017. Epub 2009 Feb 20.

PMID:
19230971
8.

Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias.

Ho AK, Hill S, Preobrazhensky SN, Miller ME, Chen Z, Bahler DW.

Am J Clin Pathol. 2009 Jan;131(1):27-32. doi: 10.1309/AJCPPAG4VR4IPGHZ.

PMID:
19095562
9.

Flow cytometric immunophenotyping for hematologic neoplasms.

Craig FE, Foon KA.

Blood. 2008 Apr 15;111(8):3941-67. doi: 10.1182/blood-2007-11-120535. Epub 2008 Jan 15. Review.

10.

CD200 as a prognostic factor in acute myeloid leukaemia.

Tonks A, Hills R, White P, Rosie B, Mills KI, Burnett AK, Darley RL.

Leukemia. 2007 Mar;21(3):566-8. Epub 2007 Jan 25. No abstract available.

PMID:
17252007
11.

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

Shaughnessy JD Jr, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, Xiao Y, Xu H, Epstein J, Anaissie E, Krishna SG, Cottler-Fox M, Hollmig K, Mohiuddin A, Pineda-Roman M, Tricot G, van Rhee F, Sawyer J, Alsayed Y, Walker R, Zangari M, Crowley J, Barlogie B.

Blood. 2007 Mar 15;109(6):2276-84. Epub 2006 Nov 14.

12.

CD200 is a new prognostic factor in multiple myeloma.

Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E, Moine P, Bourin P, Moos M, Corre J, Möhler T, De Vos J, Rossi JF, Goldschmidt H, Klein B.

Blood. 2006 Dec 15;108(13):4194-7. Epub 2006 Aug 31. Erratum in: Blood. 2007 Apr 1;109(7):2717.

13.

The molecular classification of multiple myeloma.

Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B, Anaissie E, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Walker R, Zangari M, Crowley J, Barlogie B, Shaughnessy JD Jr.

Blood. 2006 Sep 15;108(6):2020-8. Epub 2006 May 25.

14.

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Hanamura I, Stewart JP, Huang Y, Zhan F, Santra M, Sawyer JR, Hollmig K, Zangarri M, Pineda-Roman M, van Rhee F, Cavallo F, Burington B, Crowley J, Tricot G, Barlogie B, Shaughnessy JD Jr.

Blood. 2006 Sep 1;108(5):1724-32. Epub 2006 May 16.

15.

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.

Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, Stewart JP, Zhan F, Khatry D, Protopopova M, Protopopov A, Sukhdeo K, Hanamura I, Stephens O, Barlogie B, Anderson KC, Chin L, Shaughnessy JD Jr, Brennan C, Depinho RA.

Cancer Cell. 2006 Apr;9(4):313-25.

16.

Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.

McWhirter JR, Kretz-Rommel A, Saven A, Maruyama T, Potter KN, Mockridge CI, Ravey EP, Qin F, Bowdish KS.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1041-6. Epub 2006 Jan 17.

17.

Regulation of myeloid cell function through the CD200 receptor.

Jenmalm MC, Cherwinski H, Bowman EP, Phillips JH, Sedgwick JD.

J Immunol. 2006 Jan 1;176(1):191-9.

18.

Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200.

Shiratori I, Yamaguchi M, Suzukawa M, Yamamoto K, Lanier LL, Saito T, Arase H.

J Immunol. 2005 Oct 1;175(7):4441-9.

19.

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry.

McKenna RW, Asplund SL, Kroft SH.

Leuk Lymphoma. 2004 Feb;45(2):277-85. Review.

PMID:
15101712
20.

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu MR, Brown MH, Sedgwick JD, Phillips JH, Barclay AN.

J Immunol. 2003 Sep 15;171(6):3034-46.

Supplemental Content

Support Center